Image (53566d4f Ff40 4815 B922 3416cde56fb1 01)
Amlodipine Besylate And Benazepril Hydrochloride Capsule
Product Images NDC 71335-3095
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate And Benazepril Hydrochloride (NDC 71335-3095). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (53566d4f Ff40 4815 B922 3416cde56fb1 02)
Image (Aada4cd5 Cadb 42a9 8b24 Fcac5018df9e 362 1)
Image (Aada4cd5 Cadb 42a9 8b24 Fcac5018df9e 382 1)
Label (Lbl713353095)
This text contains information about a medication that is a combination of Amlodipine and Benazepril HCI. Each capsule contains Amlodipine 5 mg (as amlodipine besylate USP) and Benazepril HCI 20 mg. The dosage instructions can be found by scanning the package insert QR code. The medication should be stored at a temperature of 25°C (77°F) with excursions permitted between 15° to 30°C (59° to 86°F) as per USP standards. It is recommended to dispense in a tight container to protect from moisture and keep it out of reach of children. Manufactured by Bryant Ranch Prepack, Inc. and Lupin Limited in Burbank, CA, USA.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
